Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Protective Effect of the α2-agonist Dexmedetomidine on Mitochondrial Structure and Function for Children With Non-cyanotic Congenital Heart Defects Having Cardiac Surgery: A Randomized Controlled Trial.

NCT02299063 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02299063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02299063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Protective Effect of the α2-agonist Dexmedetomidine on Mitochondrial Structure and Function for Children With Non-cyanotic Congenital Heart Defects Having Cardiac Surgery: A Randomized Controlled Trial.
Lead sponsor
The Hospital for Sick Children
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2014
Completion date
December 31, 2019
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complication of anesthesia, ischaemia-reperfusion injury